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Abstract 
We use a set of biomarkers to measure inequality of opportunity (IOp) in the risk of 
major chronic conditions in the UK. Applying a direct ex ante IOp approach, we find 
that inequalities in biomarkers attributed to circumstances account for a non-trivial 
part of the total variation. For example, observed circumstances account for 20% of the 
total inequalities in our composite measure of multi-system health risk, allostatic load. 
We propose an extension to the decomposition of ex ante IOp to complement the mean-
based approach, analysing the contribution of circumstances across the quantiles of 
the biomarker distributions. Shapley decompositions show that, for most of the 
biomarkers, the percentage contribution of socioeconomic circumstances (education 
and childhood socioeconomic status), relative to differences attributable to age and 
gender, increase towards the right tail of the biomarker distribution, where health 
risks are more pronounced.  
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1 Introduction 
 
Health inequality has many sources, not all of which are equally objectionable. The 
existing literature focuses on socio-economic inequalities in health and variations 
associated with differences in living conditions, access to health care, and health-related 
lifestyle (e.g., Contoyannis and Jones, 2004; Baum and Ruhm, 2009). This literature 
implicitly suggests a distinction between legitimate and illegitimate inequalities. 
Building on Roemer’s (1998, 2002) influential formalisation of the concept of inequality of 
opportunity (IOp), the “egalitarian” framework does not necessarily indicate equality of 
the distribution of outcomes per se but emphasises the role of individual responsibility in 
defining a “fair” distribution (Fleurbaey, 2008; Fleurbaey and Schokkaert, 2009, 2012; 
Ramos and Van de gaer, 2016; Roemer and Trannoy, 2016).  
 
IOp has influenced the policy agenda in recent years (World Bank, 2005; NHS England, 
2017) and a growing literature has addressed the measurement of IOp in health (e.g., 
Fleurbaey and Schokkaert, 2009; Garcia-Gomez et al., 2015; Jones et al., 2012, 2014; 
Jusot et al., 2013; Li Donni et al., 2014, 2015; Rosa Dias, 2009, 2010; Trannoy et al., 2010). 
However, many of the existing studies employ subjective self-assessed health (SAH) 
measures that are inherently categorical and ordinal. This was recently acknowledged by 
Carrieri and Jones (2018), who propose a semiparametric approach to decompose ex post 
IOp into the direct contribution of efforts and the direct and indirect contribution of 
circumstances, using ratio-scaled objectively measured blood-based biomarkers in the 
Health Survey for England. 
 
The IOp approach aims at disentangling inequalities by circumstances, for which 
individuals cannot be considered responsible, and efforts, for which individuals should be 
considered responsible. As will be discussed later, there are two approaches to IOp: the 
ex-ante and the ex-post approach (eg., Fleurbaey and Schokkaert, 2009; Fleurbaey and 
Peragine, 2013; Li Donni et al., 2014). The ex post approach seeks equality of outcomes 
among people who have exerted the same degree of effort, regardless of their 
circumstances (Roemer, 1998). The ex ante approach to IOp is based on the principle that 
there is equality of opportunity if all individuals face the same opportunity set, prior to 
their efforts and outcomes being realised (Fleurbaey and Schokkaert, 2009; Van de Gaer, 
1993). The ex-ante approach suggests that all individuals have equal opportunities if (in 
expectation) no differences in outcomes emerge from having different circumstances. The 
expectation over outcomes within a circumstances type can be taken with a simple mean 
(utilitarian reward) or with some inequality aversion (Van de Gaer, 1993; Ooghe and 
Schokkaert, 2007). In light of the context for UK health policy, in this study we adopt an 
ex ante approach that focuses on inequality in the distribution of outcomes across social 
types, defined by their circumstances. We draw on the legal and health policy context to 
support this approach. 
 
With respect to the UK policy setting, a recent NHS Scotland policy report states that 
health inequalities go against the principle of social justice because they are avoidable 
(NHS Health Scotland, 2015). In particular, it is argued that “health inequalities do not 
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occur randomly or by chance, but are socially determined by circumstances largely beyond 
an individual’s control”. More broadly, NHS England draws on the international 
definition of health inequalities, as adopted by the World Health Organisation (WHO); 
health inequalities are defined as avoidable inequalities in health between groups of 
people within countries and between countries (NHS England, 2017). NHS England laid 
out the public sector equality duty to reduce health inequalities, which are set out in the 
Health and Social Care Act 2012. These health inequalities “can cut across a range of 
social and demographic indicators including socio-economic status, occupation, 
geographical location and the protected characteristics laid out in the Equality Act 2010” 
(NHS England, 2017). 
 
These obligations to address health inequalities flow down to specific chronic conditions 
such as those directly relevant to the biomarker data used in this study; for example, 
through the Healthier You: NHS Diabetes Prevention Programme that was launched in 
2016. Given that diabetes is one of the long-term conditions that may be defined as a 
disability under the Equality Act 2010, addressing diabetes prevalence is both an 
equalities issue and a health inequalities issue (NHS England, 2017). In line with the 
WHO’s targeting of cardio-vascular (CVD) health (WHO, 2007), the recent NHS Long-
term Plan highlights timely access to treatment and improving treatment of high-risk 
conditions including hypertension and high cholesterol, which are linked to CVD disease 
(NHS, 2019). Cardiovascular conditions are one of these Long-term Plan priorities, being 
largely preventable, more common in areas of deprivation and a major cause of health 
inequalities (NHS, 2019); the Long-term Plan identifies air pollution, smoking, obesity 
and poor diet as risk factors for CVD. 
 
Reducing health inequalities is therefore at the centre of the policy agenda (Bleich et al., 
2012), with the WHO calling for a global action at different levels of policy making to 
tackle health inequalities and promote the health of the more vulnerable population 
groups (Marmot et al., 2012; WHO, 2017). More specifically, in the context of the UK 
health policy, the guidance for those allocating health care resources at a local level is to 
‘…pay particular attention to groups or sections of society where improvements in health 
and life expectancy are not keeping pace with the rest of the population’ (NHS England, 
2015a). In the case of major chronic health conditions that are relevant to this study, such 
as cardiovascular conditions, diabetes and obesity, these transfers could be achieved 
through targeting of fiscal, environmental, health promotion and public health policies 
such as clean air zones, medical control of blood pressure and cholesterol, health 
education, preventative interventions and taxes on tobacco or sugary drinks (Marmot et 
al., 2012; NHS England, 2015a; Thomson et al., 2018). 
Distributive justice encompasses the fair distribution of health, since health is an 
important component of well-being and contributes to an individual’s capability to 
function (Zheng, 2011). The literature discusses the theoretical considerations on how the 
inequality concept, as initially applied to the income domain, can be transferred to the 
health domain (e.g., Culyer, 2014; Zheng, 2011). However, one of the major complications 
of the measurement of health inequality, as opposed to income inequality, is the 
measurement of health itself (e.g., Costa-Font and Cowell, 2019; Nesson and Robinson, 
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2019; Zheng, 2011). Most of the social science surveys used to measure (socioeconomic) 
inequalities in health are limited to SAH measures. SAH measures are qualitative, 
subjective assessments of individual’s health and are typically ordinal in nature. Several 
approaches have been introduced to cardinalise SAH facilitating the use of conventional 
inequality measures, however the cardinalisation methods have been criticised as an 
important source of bias (Costa Font and Hernández-Quevedo, 2013), with the relevant 
inequality results being sensitive to the cardinalisation method used (Ziebarth, 2010). 
Bond and Lang (2019) show that between-individual comparisons of well-being measures 
are fragile to different cardinalisations of the inherently ordinal data. Another 
complication with the self-reported measures of health is that they are subject to 
significant misreporting, with the reporting bias varying systematically with individual’s 
socioeconomic characteristics, posing significant implications for the robustness of earlier 
inequality studies (e.g., Bago d’Uva et al., 2008; Dowd and Zajacova, 2010; Jürges, 2007). 
Availability of ratio scale, continuous, biomarker measures may offer an attractive 
alternative here.   
In this study, we use nationally representative UK data (Understanding Society: the UK 
Household Longitudinal Study; UKHLS) to provide a comprehensive analysis of ex ante 
IOp and its underlining sources using objective health indicators. A contribution of our 
paper is that we are using nurse-collected and blood-based biomarkers that are each 
directly relevant to diagnosis, monitoring and the clinical management of specific chronic 
health conditions: obesity, high blood pressure, inflammation, diabetes and high 
cholesterol. Higher biomarker values indicate the staging or severity of the particular 
condition of interest. Over and above being objectively measured, our biomarkers are 
continuous, ratio-scale measures; thus, our inequality analysis does not depend on 
cardinalising the health outcome of interest. We use each biomarker separately and we 
also construct a composite score as a proxy measure of the cumulative wear and tear on 
the body, reflecting how repeated exposures to adverse circumstances (social, economic 
and environmental stressors) may get “under the skin” (e.g., McEwen, 2015; Seeman et 
al., 2004; Turner et al., 2016); similar composite health measures are often called 
allostatic load and have recently been used in health inequalities research (Nesson and 
Robinson, 2019).  
Given our biomarker measures, the IOp analysis in this study should be interpreted in 
terms of redistribution of the health burden and functioning and, consequently, social 
welfare with respect to the particular, preventable health condition (and its severity) that 
is directly relevant to each of our biomarkers. 
A key question is whether the Pigou-Dalton principle holds in this case. The original 
Pigou-Dalton principle states that a mean-preserving income transfer from a richer to a 
poorer person should increase the sum of social welfare. The intuition behind the Pigou-
Dalton transfer principle is not based on income as such but, more broadly, on individuals’ 
and society’s welfare, which is determined (at least partially) by income. In this utilitarian 
framework, it has been assumed that utility is an increasing and concave function of 
income, with diminishing marginal utility of income (Atkinson and Brandolini, 2015; 
Schwartz and Winship, 1980). For example, taking a dollar away from a richer person and 
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giving it to a poorer person, we decrease the first person's welfare by less than we increase 
the poorer person's welfare and, thus, we achieve an increase in the total welfare (as the 
Pigou-Dalton principle assumes). In a parallel concept, assuming that utility is an 
increasing concave function of good health, we may consider the association between 
social welfare and elevated, preventable morbidity and mortality risks as reflected in 
higher biomarker scores. As we will discuss later, medical research shows a positive and 
typically convex relationship between our biomarker scores and elevated morbidity and 
mortality. This indicates that a reduction in the spread of the biomarker value by a 
hypothetical reduction (-├) in the biomarker score from someone with a high initial 
biomarker score (i.e., someone with poor health initially and, hence, higher marginal 
utility of improving health) that is offset by an increase (+├)  in the biomarker score for 
someone with a low biomarker score (someone who is more healthy initially and hence 
with lower marginal utility of health), would increase the first persons’ welfare by more 
than we reduce the healthier person welfare; this is because utility is assumed to be an 
increasing concave function of health and that the medical evidence suggests that the 
harm associated with the biomarkers we use tends to be steeper for higher biomarker 
scores (those in poorer health). Overall, based on the evidence from the clinical literature 
presented below, we maintain the assumption that the Pigou-Dalton principle holds for 
our biomarkers and the analysis in our paper. 
We use the objective health measures to estimate both absolute measures of the level of 
IOp and measures that express IOp as a fraction of the overall inequality in our health 
measures. We adopt the direct ex ante parametric approach proposed by Ferreira and 
Gignoux (2011, 2013). The advantage of the parametric approach is that, unlike 
nonparametric tests for IOp (e.g., Lefranc et al., 2009; Rosa Dias, 2009), it does not suffer 
from a curse of dimensionality, due to insufficient sample sizes for social types (groups of 
people sharing identical circumstances).1 Moreover, even in the presence of unobserved 
circumstances, our IOp measures can be interpreted as the lower-bound estimates of 
overall IOp, i.e., of the inequality due to all circumstances, not only those that are 
observed (Ferreira and Gignoux, 2011). 
 
We decompose the direct ex ante measure of IOp in our health measures into its sources. 
Shapley-decomposition techniques allow us to identify which circumstances are more 
relevant to shaping IOp in our biomarker measures. Given that age and gender are 
principal drivers of variations in health, the sample is then split by gender and by age 
groups to analyse the extent of IOp  that is relevant to circumstance variables apart from 
age or gender and how these inequalities may vary by gender and across the adult 
lifespan2. 
 
                                                             
1 Maintaining a reasonable number of observations within each social type is a challenging issue 
given the usual sample sizes of social-science datasets and the relatively large number of 
circumstances that empirical researchers wish to use to partition the population by types (Ferreira 
and Gignoux, 2011; Carrieri and Jones, 2018).   
2 For example, it has been shown that the association between education and health may follow 
heterogeneous patterns by age and gender (e.g., Davillas et al., 2017; Baum and Ruhm, 2009). We 
extend this literature to the IOp context by exploring differential patterns by age and gender.       
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Finally, we relax the assumption of inequality neutrality within types, that is implied by 
the conventional parametric approach, and extend the literature on the decomposition of 
ex ante IOp, capitalising on the continuous nature of our health outcomes. We use the 
recentered influence function (RIF) approach to distributional analysis (Firpo et al., 2009), 
to explore how the contribution of circumstances may vary across the distribution of 
biomarkers. Shapley decompositions are implemented at different quantiles of the 
biomarker distribution to explore the underlying sources of these inequalities, with a 
particular focus on the right tails, where clinical concerns are typically focused. We again 
split the sample by gender and by age groups to analyse the contribution of socioeconomic 
circumstances (apart from age and gender) at different biomarker quantiles, spanning the 
whole distribution of our health measures.  
 
 
2 Methods  
 
Roemer (1998) assumes a responsibility cut by which factors associated with individual 
attainments can be partitioned into: a) effort factors, for which individuals should be held 
partially responsible, and b) circumstances which are beyond individuals’ control. 
Following the IOp in health literature (Carrieri and Jones, 2018; Jusot et al., 2013; Rosa 
Dias, 2010), a generalised health production function for the health outcome (検沈) for each 
individual 岫件岻 can be defined as a function of a vector of circumstances (系沈) and of efforts 
(継沈). Assuming that circumstances are not affected by efforts, while efforts may be 
influenced by circumstances (Bourguignon et al., 2007; Ferreira and Gignoux, 2011; 
Roemer, 1998, 2002), we can write: 
 検沈 噺 月岫系沈 ┸ 継岫系沈 ┸ 懸沈岻┸ 憲沈 岻                                                       (1) 
 
where 懸沈 and 憲沈 are unobserved error terms which capture the random variation in the 
realised outcomes, sometimes labelled as ‘luck’ in the IOp literature (Lefranc et al., 2009; 
Lefranc and Trannoy, 2017).3 To be specific, 懸沈 represents random variation in effort that 
is independent of C and 憲沈 represents random variation in the outcome that is 
independent of C and E. 
 
In principle, the structural form (1) can be used in an ex post framework to decompose the 
direct and indirect contribution of circumstances and efforts. Here we adopt an ex ante 
approach and are interested in measuring overall IOp as a share of total inequality. Then, 
assuming additive separability and linearity of 月岫┻ 岻 and 継岫┻ 岻, a linear reduced form can 
be derived: 
 
                                                             
3 In the Roemerian framework, the partial correlations between C and E should also be treated as 
circumstances, embodying the indirect effect of the unjust circumstances on health that is 
channelled through effort (see Ferreira and Gignoux, 2011; Rosa Dias, 2009). This is embodied in 
the reduced form coefficients that capture both direct and indirect effects. However, the ethical 
stance of the Roemer concept is open to debate. Examples of empirical methods to compare the 
Roemer view with other more liberal perspectives are available elsewhere (Jusot et al., 2013). 
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検沈 噺  系沈閤 髪 綱沈                              (2) 
 
where the coefficients 閤 reflect the total contribution of circumstances and include both 
the direct effect of circumstances on health, and the indirect effect of circumstances 
through efforts.  
 
The ex ante approach to IOp is based on the principle that there is equality of opportunity 
if all individuals face the same opportunity set regardless of their circumstances and prior 
to the realisation of effort and the outcomes. The ex ante approach can be implemented 
empirically using information on observed circumstances and does not require measures 
of effort. These circumstances are used to measure the opportunity set for each individual 
(e.g., Aaberge et al., 2011; Fleurbaey and Peragine, 2013; Ooghe et al., 2007; Van de gaer, 
1993). Two approaches have been adopted to do this: 
i. The first uses the mean of outcomes within types, 継岫検沈】系沈 岻. This corresponds to the 
approach suggested by Roemer (1998, 2002) and has been termed “utilitarian reward”. 
This implies inequality neutrality within types. Jones et al. (2014) note the equivalence 
between the mean and the area to the left of the distribution function, 繋岫検沈】系沈岻, and they 
therefore use this as their criterion for health policy evaluation.  This can therefore be 
considered as a 'mean-based' approach, where equality of opportunity corresponds to 
equality of mean outcomes across types (e.g., Ferreira and Gignoux, 2011, 2013; Lefranc 
et al., 2009; Van de gaer, 1993). 
 
ii. The second approach uses a more general definition that interprets the full type-specific 
conditional outcome distribution 繋岫検沈】系沈岻 as the opportunity set (e.g., Lefranc et al., 2009; 
Lefranc and Trannoy, 2017; Ooghe et al., 2007; Ramos and Van de gaer, 2016). This goes 
beyond the mean-based approach, focusing on differences in distributions across types, 
and allows for the possibility of inequality aversion within types such that, for example, 
more significance is attached to inequalities across types at worse levels of health 
outcomes. The implications of this second approach are explored using a distributional 
regression approach that is described below. 
 
Figure 1 illustrates these concepts for the case where there are just two values of 
circumstances, represented by types 1 and 2. The ex ante approach compares the 
distribution of outcomes conditional on type, as shown in the left-hand panel, and 
interprets these distributions as the opportunity set for each type. In particular, the 
mean-based approach focuses on differences in means across types, given by the area to 
the left of the distribution functions and hence, in this case, shown by the dark shaded 
area in the right-hand panel. Differences in means is regarded as a weak test for IOp. A 
stronger test takes account of the shape of the distribution within types and, depending 
on the degree of inequality aversion within types, may give more weight to horizontal 
differences between the distributions at different levels of the outcome4. This motivates 
                                                             
4 In the context of our application to biomarkers the notion of inequality aversion within types may 
be motivated by the fact that these are measured in physical units, 検沈, which may not correspond 
to their social value, say 降岫検沈岻. For example, rather than being linear, the function 降岫┻ 岻 may give 
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our analysis of the contribution of circumstances at different points of the biomarker 
distribution.   
 
 
Figure 1. Ex ante IOp and distribution functions. 
 
 
 
 
We begin with the mean-based framework. The direct approach, as in Ferreira and 
Gignoux (2011), measures inequality in a counterfactual in which all inequalities are 
attributable to circumstances. This involves defining a smoothed distribution from the 
distribution of (health) outcomes 岫検沈岻 and a partition of 岫倦 噺 な┸に┻ ┻ 計岻 types by replacing 
each individual health outcome 検沈賃 with the relevant type-specific mean 岫航沈賃岻 and, then, 
using inequality indexes to measure IOp (Ferreira and Gignoux, 2011).5  In practice, the 
mean-based direct parametric approach to measure ex ante IOp is based on using 
predictions of 継岫検沈】系沈岻 from the reduced form as the counterfactual outcome: 
 検徹蕪 噺  系沈閤侮                                                        (3) 
 
where 閤侮 represents the OLS estimates of the coefficients in equation (2) (Checci and 
Peragine, 2010; Rosa Dias, 2010; Trannoy et al., 2010; Ferreira and Gignoux, 2011, Li 
Donni et al., 2014; Abatemarco, 2015). The predicted health outcomes are the same for all 
individuals with identical circumstances (Ferreira and Gignoux, 2011). Thus, IOp can be 
estimated using an inequality measure 岫荊岫┻ 岻岻 applied to 検徹蕪 :    
 肯銚 噺 I岫検徹蕪岻┻                                                        (4) 
 
                                                             
different weight to outcomes above or below the clinical risk thresholds that are associated with 
some of the biomarkers. 
5 The indirect approach (as in, for example, Bourguignon et al., 2007) uses the difference between 
inequality in actual outcomes and a counterfactual in which there is no IOp, calculated using a 
reference level of circumstances. We have opted for the direct approach in our analysis. Parametric 
estimation shows that the direct and indirect approaches result in similar, but not exactly 
identical, results (Ferreira and Gignoux, 2011); this is typical, given the functional form 
assumptions that are relevant to parametric estimation models.    
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A relative measure of IOp, expressing IOp as a fraction of the overall health 
inequality  岫荊岫検沈岻岻, can be obtained by: 
 
 肯追 噺 瀧岫槻伯蕪 岻彫岫槻日岻┻                                                           (5) 
 
Following Ferreira and Gignoux (2011), we use the mean logarithmic deviation (MLD) 
inequality index as our principal measure of inequality I(.). They adopt the MLD because 
of its path-independent decomposability properties (Checchi and Peragine, 2010; Ferreira 
and Gignoux, 2011; Ramos and Van de Gaer, 2016; Wendelspeiss Chávez Juárez and 
Soloaga, 2014). If I(.) needs to satisfy the path-independent decomposability axiom in 
addition to other typical axiomatic properties relevant to the measurement of inequality 
literature, i.e., symmetry, transfer principle, scale invariance and population replication 
this restricts the eligible “path-independent decomposable” class of inequality measures 
for the case of ratio-scale outcomes (as with our biomarkers) to a single measure, the MLD 
(Ferreira and Gignoux, 2011). The main advantage of the decomposability axiom for the 
purpose of our analysis is that it allows us to decompose total inequality into the share 
attributed to circumstances and a residual (eq. 3, 4 and 5) (Checchi, and Peragine, 2010; 
Ferreira and Gignoux, 2011). To check the robustness of our findings we complement our 
results by adding a sensitivity analysis to show how our decomposition of the MLD 
compares to the variance share. The variance share is the share of the total variance in 
our biomarkers that is attributed to circumstances and is a relative IOp measure that 
satisfy all standard axioms and the axiom of the path independent decomposability, but 
is more appropriate for outcomes that are not ratio-scaled, unlike our biomarker data 
(Ferreira and Gignoux, 2013; Wendelspeiss Chávez Juárez and Soloaga, 2014).6 
 
The MLD is zero when there is no inequality, and takes on larger positive values as ill-
health is distributed more unequally. It should be explicitly noted here that our analysis 
does not account for unobserved circumstances that are not available in the dataset. 
However, it has been shown that equations (4)-(5) can be interpreted at least as the lower-
bound estimates of inequality due to all predetermined circumstances (Ferreira and 
Gignoux, 2011). 
 
Decompositions of IOp 
We use the Shapley decomposition to explore the contribution of each of the circumstances 
to the total IOp in health (Fajardo-Gonzalez, 2016; Shorrocks, 2013; Wendelspeiss Chávez 
Juárez and Soloaga, 2014). Specifically, inequality measures for all possible permutations 
of the circumstance variables are estimated and, then, the average marginal effect of each 
circumstance variable on the total IOp is calculated. The key advantage of the Shapley-
decomposition, unlike other decomposition methods, is that it is both path independent 
and exactly additive, with the different components sum up exactly to the total IOp 
(Fortin et al., 2011; Wendelspeiss Chávez Juárez and Soloaga, 2014). This makes the 
                                                             
6 However, inequality measures based on the variance have been used in the existing IOp (in 
health) literature (e.g., Carrieri and Jones, 2018; Ferreira & Gignoux, 2013; Garcia-Gomez et al., 
2015; Jusot et al., 2013).  
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additive decomposability property of the MLD less of a distinctive advantage and we apply 
the Shapley decomposition to the variance in our robustness checks. 
 
Given that age and gender are the main sources of variation in health, we then use a split 
sample analysis to further analyse gender and age differentials in IOp. This involves 
estimating IOp separately for each population sub-group (i.e., by gender and across age 
groups), exploring the role of circumstance variables apart from age or gender.  
 
Using distributional regressions to relax inequality neutrality within types 
The methods described so far measure and decompose overall IOp in health using linear 
parametric regression specifications and a counterfactual based on the conditional mean. 
As noted above, this implies inequality neutrality within types. In our context this may 
be too restrictive and, for example, we may wish to give greater weight to the contribution 
of circumstances in the upper tail of the distribution of biomarkers, where individuals are 
at greater risk of developing chronic health problems. 
 
To assess the implications of relaxing inequality neutrality we propose a method of 
decomposing the contribution of circumstances to the overall IOp at different points in the 
distribution of the outcome. This makes use of unconditional quantile regression (UQR) 
based on the RIF approach (Firpo et al., 2009) to decompose the contribution of 
circumstances at specific quantiles of the biomarker distributions.  
 
The RIF method works by providing a linear approximation of the unconditional quantiles 
of each biomarker. Subsequently, the law of iterated expectations is applied to the 
approximated quantile and used to estimate the marginal effect of circumstances through 
a regression of the RIF on the circumstance variables. The total contribution of 
circumstances, at each quantile 圏邸, can be then obtained by:  
 迎荊繋岫検沈┹ 圏邸岻 噺 系沈 糠邸 髪 綱沈邸                       (6) 
 
where 糠邸 are the coefficients at different quantiles and  綱沈邸 stands for the error term. This 
is illustrated by Figure 2, which shows how the RIF regressions aim to capture differences 
attributable to circumstances at specific quantiles of the distribution, represented here by 
the horizontal line at the 60th percentile.  
 
Then the counterfactuals used in the direct approach are given by:  
 検徹邸葺 噺 系沈糠邸武                        (7) 
 
The variation in these fitted values, which capture the role of circumstances since 
counterfactuals 岫検徹邸葺 岻 are the same for all individuals with identical circumstances (in line 
with the concept of the direct ex ante IOp), can be summarized using an inequality index 
(here we again use the MLD, as in equation 4). As the RIF equations are additive and 
linear, the Shapley decomposition and split sample analysis can be then applied to this 
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index to explore the contribution of each circumstance variable as well as differentials in 
their contribution by gender and age at different quantiles of biomarker distribution.   
 
 
 
 
Figure 2. Distributional regressions. 
 
 
 
 
 
 
3     Data 
  
The data come from UKHLS, a longitudinal, nationally representative study of the UK. 
We use the General Population Sample (GPS) component of UKHLS, a random sample of 
the general population. As part of wave 2 (2010-2011), nurse-measured and non-fasted 
blood-based biomarkers were collected for the GPS. The wave 2 nurse visits included 
15,632 respondents, while blood-based biomarkers impose further restrictions on the 
sample since they require the successful collection and processing of blood samples.7 
Exclusion of missing data on covariates reduces the potential sample to a maximum of 
14,068 and 9,005 individuals with valid nurse-collected measurements and blood-based 
biomarkers, respectively.  
 
Biomarkers  
We focus on physical measurements and blood-based biomarkers that are directly 
relevant to major chronic conditions such central obesity, high blood pressure, 
inflammation, diabetes and high cholesterol. Our nurse-collected measurements are the 
waist-to-height ratio (WHR), defined as waist circumference over height, being a validated 
measure of central adiposity (Swainson et al., 2017) and systolic blood pressure. Our 
                                                             
7 Respondents were eligible for nurse visits if they were aged 16+, lived in England, Wales, or 
Scotland, and were not pregnant. Blood sample collections were further restricted to those who 
had no clotting disorders and no history of fits. 
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blood-based biomarkers reflect ‘fat in the blood’, ‘sugar in the blood’ and markers for 
inflammation. The cholesterol ratio, the ratio of total cholesterol over high-density 
lipoprotein, is our ‘fat in the blood’ biomarker used for diagnosis, staging and monitoring 
of high cholesterol. High levels of the cholesterol ratio are associated with increased risk 
of cardiovascular conditions. Glycated haemoglobin (HbA1c) is a standard diagnostic test 
for diabetes. Given that no single inflammatory biomarker can capture all aspects of 
inflammation because of the complexity of the inflammatory profiles (Castagné et al., 
2016; Davillas et al., 2017), two inflammatory biomarkers are used in our analysis due to 
data availability: C-reactive protein (CRP) and fibrinogen8. CRP rises as part of the 
immune response to infection. Fibrinogen is a glycoprotein that aids the body to stop 
bleeding by promoting blood clotting, and is regarded as an inflammatory biomarker 
(Davillas et al., 2017).  
 
In addition to each of the specific markers, we also combine them in a composite measure, 
which gives an overall assessment of a respondent’s physiological condition. We construct 
an index of multi-system risk, often called allostatic load (e.g., Davillas and Pudney, 
2017). Allostatic load is elevated when a person’s biological systems are affected by 
repeated stressors, resulting in persistently elevated or altered levels of a number of 
biomarkers associated with ‘chronic stress’. Allostatic load is, thus, a measure of 
cumulative wear and tear in a number of physiological systems. As such, it is an ideal 
health measure for the purpose of the measurement of IOp because it captures chronic 
physiological responses that are associated with social and environmental stress and, 
thus, can be considered as more proximal outcomes in the process through which economic 
and social circumstances may get “under the skin” across the lifespan (Davillas et al., 
2017; McEwen, 2015; Seeman et al., 2004). 
 
The literature on the measurement of allostatic load has shown that a single additive 
measure of the different biomarkers is sufficient to measure allostatic load (Howard and 
Sparks, 2016).9 Specifically, our composite measure combines all six nurse-collected and 
blood-based biomarkers considered in our study: WHR, systolic blood pressure, HbA1c, 
CRP, fibrinogen and cholesterol ratio. We then transform each of these biomarkers into 
standard deviation units and sum them (Davillas and Pudney, 2017; Howard and Sparks, 
2016; Seeman et al., 2001). Higher values of allostatic load indicate worse health. 
 
It should be noted here that the biomarkers used in our analysis are surrogate markers 
of cardiovascular and total mortality risks, being at the centre of causal pathogenic 
                                                             
8 It has been shown that relying only on one inflammatory marker makes generalisations of the 
results to inflammatory burden uncertain. For example, because of the natural complexity of the 
inflammatory mechanisms, such as synergistic or offsetting effects, analysis needs to account for 
more inflammatory biomarkers rather than rely on CRP alone (Castagné et al., 2016; Davillas et 
al., 2017). Moreover, there are concerns whether CRP captures recent infections rather than 
systematic inflammation (Povoa et al., 2005), which indicates that results on CRP may be 
contaminated by recent infections.   
9It has been shown that individual biomarkers commonly used to calculate allostatic load do not 
differ in their strength of association, or factor loadings, to a single underlying factor structure of 
allostatic load. Thus, simple, additive measures of allostatic load are sufficient to model allostatic 
load (Howard and Sparks, 2016; Seeman et al., 2001).  
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mechanisms10. To highlight the shape of the association between our biomarkers and all-
cause mortality risks, we summarise some of the existing evidence from the medical 
literature. Mortality hazards are an increasing function of WHR across its distribution, 
with a steeper risk profile at the higher quantiles of the distribution (Ashwell et al., 2014). 
Systolic blood pressure is considered as more relevant to cardiovascular mortality risks 
as opposed to diastolic blood pressure, with mortality risks being steeper at higher levels 
of systolic blood pressure (Bundy et al., 2017). The cholesterol ratio has the advantage 
that it involves the opposing effects of “bad” and “good” cholesterol varieties on health and 
is considered as a stronger predictor of all-cause mortality risks than each of the 
individual cholesterol concentrations (Prospective Studies Collaboration, 2007); it has 
been shown that cardiovascular mortality risks gradually increase, with a weaker 
associations at the lower levels of cholesterol ratio and steeper associations at higher 
levels (Prospective Studies Collaboration, 2007). Implications on individual’s health are 
not homogeneous across the HbA1c distribution, with higher values being an increasing 
function of diabetes severity, morbidity and mortality risk. There is a J-shaped association 
between HbA1c and cardiovascular disease and cancer mortality risks (Zhong et al., 2016). 
Turning to our inflammatory biomarkers, CRP has a J-shaped association with 
cardiovascular and non-cardiovascular mortality risks, with the association being steeper 
at the higher CRP levels (Emerging Risk Factors Collaboration, 2010). All cases mortality 
rates are a progressively increasing function of fibrinogen, with stronger associations at 
the higher fibrinogen quantiles (Acevedo et al., 2002; Danesh et al., 2005). Our composite 
health measures, allostatic load, is a strong predictor of future mortality risks with a 
“dose-response” association that is more pronounced and steeper at higher allostatic load 
values (Castagné et al., 2018; Seeman et al, 2004). 
 
Note that our biomarkers are ratio scaled, i.e., they have a true zero value and their 
measurement scale is unique up to a proportional scaling factor. Specifically, they are 
measured in natural units: CRP (mg/L), cholesterol ratio (both total cholesterol and high-
density lipoprotein cholesterol are measured in mmol/L), fibrinogen (g/L), HbA1c 
(mmol/mol), systolic blood pressure (mmHg) and WHR (both waist circumference and 
height are measured in cm). Our measure of allostatic load is the sum of these biomarkers, 
standardised by their standard deviations, and is invariant to rescaling of the individual 
biomarkers.11 
 
 
                                                             
10 A few biomarkers can achieve surrogate endpoint status as they need to satisfy a number of 
criteria to ensure causal links to the pathogenic mechanisms to the elevated mortality risks 
(Aronson, 2005; Biomarkers Definitions Working Group, 2001). Our biomarkers are carefully 
selected as good surrogate measures of mortality risks in several clinical trials and medical 
research. For example, blood pressure, cholesterol levels and CRP are considered as good surrogate 
measures of a number of life-threatening events (Weintraub et al., 2015; Welsh et al., 2017). 
11 Given the absence of longitudinal data on biomarkers, our results should not be viewed and 
interpreted as a lifetime health achievements approach to measure and analyse IOp in health. 
Recall however, as a potential way to alleviate these concerns, that our biomarkers reflect the risk 
for chronic conditions and that allostatic load measures the cumulative wear and tear of several 
physiological systems due to repeated exposure to social, economic and environmental 
disadvantages. 
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Circumstances  
The choice of measured circumstance factors follows the recent empirical literature, 
informed by the normative framework for health equity and the UK policy and legal 
context (Carrieri and Jones, 2018; Rosa Dias, 2009, 2010; Jusot et al., 2013). Our 
circumstance variables embody the ethical position of the responsibility cut, defining 
illegitimate sources of health inequality. 
 
Specifically, we have adopted Roemer’s pragmatic approach of drawing on the socio-legal 
context of the analysis to inform the responsibility cut and to define relevant 
circumstances. Our paper addresses IOp in health in the United Kingdom and hence the 
legal duties with respect to health inequality that face the National Health Service (NHS) 
help to define that context. For example, NHS England’s inequality aims include: 
“advance equality of opportunity between persons who share a relevant protected 
characteristic and persons who do not share it” (NHS England, 2015b), where the 
protected characteristics are defined by the Equality Act 2010 and include age, sex and 
race. This is reinforced by the evidence on differential healthcare and social care 
treatment by age and gender regardless of healthcare need (Department of Health, 2012; 
Oliver, 2009). One way in which these aims are put into practice is through NHS 
England’s 2015 guidance on monitoring equality and health inequalities (NHS England, 
2015b); the categories for collecting information on equality include the protected 
characteristics under the Equality Act 2010, such as age, sex and race, as well as 
information on socio-economic factors and educational attainment. 
 
The Equality Act of 2010 defines protected characteristics that include age, sex and race. 
We treat sex and age (dummies for 10-year intervals between 16 and 75 and a dummy for 
75+) as circumstances (Carrieri and Jones, 2018). Nationality and linguistic background 
is proxied by a dummy for speaking English at home during childhood. It should be noted 
however that it is unlikely to achieve universal agreement. In the IOp in health literature 
existing studies treat age and gender as either legitimate or illegitimate sources of health 
inequalities. Either way, the demographic variables are included in the reduced form 
regressions for health outcomes in all of these studies (e.g., Carrieri and Jones, 2018; 
Garcia Gomez et al., 2015; Jusot et al., 2013; Li Donni et al., 2014; Trannoy et al., 2010). 
However, the way that these variables are handled in subsequent decomposition or 
counterfactual analyses differs depending on whether they are treated as demographic 
controls (and, thus, should be included in the regression analysis but not treated as 
circumstances in the measurement and decomposition of IOp) or, at least to some extent, 
as circumstances. Garcia-Gomez et al. (2015), in their review analysis on legitimate or 
illegitimate sources of health inequalities, argue that the normative status of any age- 
and gender-specific standardisation is not clear in the case of the IOp literature and they 
remain agnostic regarding whether age and gender should to be treated as either 
legitimate or illegitimate sources of health inequalities. Specifically, the association of age 
and gender with the biomarkers cannot be considered as entirely “irremediable” and may 
vary over time, depend on (health) policy and be influenced by socially constructed roles 
and relationships (Connell, 2012; Doyal, 2001; Garcia-Gomez et al., 2015; Rieker and Bird, 
2005). The advantage of our Shapley decompositions is that the results can be interpreted 
under either perspective, as the analysis allows us to identify the contributions of age and 
14 
 
gender separate from the other circumstance variables. In the spirit of Garcia-Gomez et 
al. (2015), this analysis allows the reader to draw their own conclusions regarding the 
responsibility cut and, for example, to disregard the contribution of age or gender if they 
wish. Nevertheless, we note that the decomposition only provides upper and lower bounds 
on the contribution of age and gender. 
 
The Equality Act 2010 does not directly encompass socioeconomic status (SES) among its 
protected characteristics but this has been a concern of the existing literature on IOp. 
Childhood SES is regarded as an important source of IOp in health, being beyond 
individual’s control and exerting a lasting effect on individual’s adult health (Jusot et al., 
2013; Rosa Dias, 2009, 2010). We use both parental occupational status and education to 
proxy childhood SES. The occupational status of the respondent’s mother and father, 
when the respondent was aged 14, is measured using two categorical variables (one for 
each parent) with six categories: not working (reference category), four occupation skill 
levels (based on the skill level structure of the Standard Occupational Classification 2010) 
and a category for missing data. Given the high correlation between mother’s and father’s 
education, we combine them creating a measure capturing the highest parental education 
level (Kenkel et al., 2006). This is a five category variable measured as: left school with 
no/some qualification (reference category), post-school qualification/certificate (e.g., an 
apprenticeship), degree (university or other higher-education degree) and a missing data 
category.12  
 
The legal and policy context in the UK also frames the notion of an age of responsibility. 
This age varies across different dimensions such as criminal responsibility and age of 
consent. Young people aged over 18 are treated as an adult by the law. Here we make the 
normative assumption that the level of secondary schooling achieved by age 18 is beyond 
individual’s responsibility, influenced by parental and environmental factors during 
individual’s earlier life, and therefore individuals’ own education constitutes a 
circumstance (Jones et al., 2012; Carrieri and Jones, 2018). Education is measured as: 
no/basic qualification (reference), O-Level, A-Level/post-secondary and degree. 
Descriptive statistics for circumstances and biomarkers are available in Tables A1 and 
A2 (Appendix).  
 
 
 
 
 
                                                             
12 Comparison of summary statistics for the biomarkers reveals similar results for our working 
sample and the sample restricted to non-missing parental information (Table A2, appendix), 
suggesting that the use of missing categories or the exclusion of missing data on parental 
characteristics should have limited implications for our analysis. 
15 
 
 
4 Results  
 
4.1. Mean-based measures of ex ante p 
 
Table 1 presents inequality results for the different biomarkers and for allostatic load. 
Column [a] shows the total inequality, measured by the MLD. Observed circumstances 
account for a non-trivial part of the total inequalities as our results from the mean-based 
ex ante IOp measures show (columns [b]-[c]). The contribution of measured circumstances 
to the total inequality is lowest for CRP (4%), it is higher for cholesterol ratio, fibrinogen 
(11%) and waist-to-height ratio (17%) and around 20% for systolic blood pressure, HbA1c 
and allostatic load.  
 
 
 
Table 1. Total inequality and IOp (MLD indexes).  
  IOp 
Sample 
size  
Total inequality 
[a] 
Absolute IOp 
[b] 
% of total 
inequality [c=b/a] 
Waist-to-height ratio 
0.0116*** 
(0.0001) 
0.0020*** 
(0.00007) 
16.9% 14,068 
Systolic blood pressure 
0.0087*** 
(0.0001) 
0.0017*** 
(0.00007) 
19.8% 11,865 
Cholesterol ratio 
0.0583*** 
(0.0010) 
0.0064*** 
(0.0004) 
11.0% 9,005 
HbA1c 
0.0153*** 
(0.0006) 
0.0030*** 
(0.0002) 
19.5% 8,468 
CRP 
0.4244*** 
(0.005) 
0.0161*** 
(0.0020) 
3.9% 8,311 
Fibrinogen 
0.0218*** 
(0.0004) 
0.0023*** 
(0.0002) 
10.7% 8,964 
Allostatic load 
0.0074*** 
(0.0001) 
0.0016*** 
(0.0001) 
21.8% 6,166 
Bootstrapped standard errors in parenthesis (500 replications). 
***P<0.01 
 
 
 
Specifically, Table 1 shows systematic total inequalities that follow heterogeneous 
patterns across biomarkers (column a). Beyond CRP, for which the total inequality is 
much larger compared to all other biomarkers, overall inequality is higher for our fat in 
the blood biomarker (cholesterol ratio), fibrinogen, diabetes biomarker (HbA1c) and for 
our measure of adiposity. The contribution of measured circumstances to the total 
inequality ranges between 11-20% for most of the biomarkers (Table 1, columns b and c)13 
and is broadly in line with previous studies on the presence of considerable social and 
economic patterning in several cardiovascular risks, such as obesity, diabetes, 
hypertension and cholesterol (e.g., Baum and Ruhm, 2009; Brunello et al., 2013; Cohen et 
al., 2010).  
                                                             
13 Although different techniques and biomarkers are employed by Carrieri and Jones (2018), our 
results regarding HbA1c (the only biomarker in common) are comparable, with IOp accounting for 
up to 19% of the total (including the unexplained) inequalities in HbA1c in their analysis of the 
Health Survey for England.   
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It should be noted that CRP is a clear outlier here, having a very large overall inequality, 
while the contribution of the observed circumstances to the total inequality is the lowest 
(about 4%). The large total CRP inequality may reflect the fact that CRP is an acute-phase 
biomarker, which may increase up to 1,000-fold in the presence of infection or 
inflammation (e.g., Sproston and Ashworth, 2018); this indicates that CRP values vary 
considerably between the healthy and less healthy sub-populations resulting in large 
overall inequalities. We need to recap here that CRP may capture recent infections, rather 
than chronic systematic processes, which may be less relevant to circumstances and more 
likely due to unobserved factors. This may explain why circumstances account for such as 
small part of the total inequalities, unlike the results for our alterative inflammatory 
biomarker (fibrinogen).14  
 
We then explore the contribution of each of the circumstances to IOp using the Shapley-
decomposition (Figure 3).15 Age and gender (in combination) account for the largest part 
of the IOp in almost all the biomarkers (except CRP), and age accounts for the dominant 
contribution; this is in line with literature on the role of age and gender on explaining 
variations in health (e.g., Baum and Ruhm, 2009). Individuals’ education and parental 
occupational status are the second and third sources of IOp, while parental education is 
the fourth contributor. Respondents’ education, parental occupation and parental 
education account for 15%, 8% and 6% of the total IOp in allostatic load, respectively.16 
                                                             
14 CRP may reflect recent infections rather than solely systematic/chronic inflammation. Although 
in this study we have excluded those individuals with CRP levels over 10 mg/dL to partially account 
for this, there is no consensus regarding how (or if it is feasible) to eliminate the potential role of 
recent infections in CRP concentrations (Povoa et al., 2005). In any case, exclusive reliance on CRP 
cannot capture all aspects of inflammation (Castagné et al., 2016; Davillas et al., 2017) and, thus, 
given the aforementioned shortcomings, our results on fibrinogen are of particular importance 
here.  
15 It should be noted here that the Shapley decomposition analysis may facilitate a standardisation 
of the health outcomes, which could be equivalent to an “indirect” age and gender standardisation 
of the health outcomes (O'Donnell et al., 2008). The advantage of the Shapley decomposition is that 
it allows us to identify the contributions of age and gender separate from the other circumstance 
variables. In line with our discussion in the circumstances sub-section, this analysis allows the 
reader to draw their own conclusions regarding the responsibility cut. For example, if someone 
assumes the pure “control” view, the contributions of age and gender could be deducted from the 
measure of IOp and this could be used in policy evaluation. Future research that accounts and 
compares alternative standardisation methods may be useful in case that someone takes the view 
that the role of age and gender is purely “natural”.  
16 As it has been shown by Ferreira and Gignoux (2011), our analysis should be viewed as a lower 
bound of the share of inequality associated with all circumstances, both observed and unobserved. 
In the spirit of Ferreira’s and Gignoux’s (2011) arguments, if age and gender are not included in 
our set of circumstances, then, the share of inequality attributed to the other circumstances 
included in our analysis may be over-/under-estimated (depending on their correlation with the 
omitted age and gender variables); but, our IOp approach still would be considered as a lower 
bound of the total true IOp, attributed to observed and unobserved (in our analysis) circumstances. 
By including age and gender in our analysis, following all previous literature of IOp in health, we 
are able to quantify the contribution of all socio-economic circumstances net of the potential (direct 
and indirect) role of age and gender. Still, however, our absolute and relative IOp measures should 
be viewed as lower bounds of the possible true measures of (ex-ante) IOp. 
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Figure 3. Shapley decomposition of circumstances to IOp. 
 
 
 
As discussed earlier, we conducted sensitivity analysis to show how our results based on 
the MLD index compare to the variance share. Table A3 (appendix) shows that our results 
presented above, based on the MLD index, and those on the variance share (in terms of 
both the relative IOp measures and the contribution of circumstances to IOp) are 
practically identical. Given that the MLD is scale invariant but not translation invariant, 
while the variance share is both scale and translation invariant (Ferreira and Gignoux, 
2013), these sensitivity analysis results may alleviate concerns regarding the robustness 
of our finding with respect to the measurement of inequality. 
Given that age and gender are the main sources of variation in health, a split sample 
analysis is used to explore differentials in the IOp in allostatic load between women and 
men and across age groups (Figure 4). IOp is evident for both genders, being higher for 
women than for men (p-value for gender IOp difference: 0.000). These results are in line 
with recent evidence suggesting that low socio-economic position is more consistently 
associated with a worse profile of biomarkers for cardiovascular health for women rather 
than for men (Kavanagh et al., 2010).  
 
Figure 4 also presents the results of the corresponding split sample analysis of IOp in 
allostatic load by age group. We find that IOp in allostatic load varies substantially across 
the adult lifespan, being higher for the 26-35 and 36-45 age groups compared to younger 
and older ages. These results highlight the role of circumstances other than age on 
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shaping IOp in health and reflect the IOp patterns across the adult life span. Our mean-
based analysis shows that the cross sectional health inequalities increase with age up to 
a limit and then inequality begins to narrow most likely due to the age-as-leveller 
hypothesis (Baum and Ruhm, 2009; Davillas et al, 2017); the latter suggests that, as far 
as analysis at the mean of the allostatic load distribution is considered, unavoidable 
biological processes may dominate the social determinants on health at older ages.  
 
 
Figure 4. IOp in allostatic load by gender and age. 
 
 
 
4.2. Distributional analysis of the contribution of circumstances 
 
Unconditional quantile regression (UQR) models are estimated to measure the 
contribution of measured circumstances across the biomarker distribution and Shapley 
decomposition analysis is then used to explore the contribution of circumstances at each 
quantile (Table 2).  
 
Our results show the presence of systematic variation attributable to circumstances for 
all health outcomes across the whole distribution (as shown by the MLD indexes).  The 
most striking result from the Shapley decomposition shows that the percentage 
contribution of socioeconomic circumstances, measured by parental occupation, education 
and individual’s education, increases towards the right tail of the biomarker distribution 
for most of the biomarkers. For example, the contribution of parental occupation for 
allostatic load increases from 7% (25th quantile) to 17.4% (95th quantile). It is also notable 
that, in most cases, the relative contribution of age and sex declines, relative to that 
attributed to socioeconomic factors, in the right hand tails, where individuals are most at 
risk of health problems. For example, the joint contribution of age and gender for allostatic 
load at the 25th quantile is 78%, while socioeconomic circumstances (parental occupation, 
parental education and own education) account for 21%; the corresponding contributions 
are almost equal (around 50%) at the top quantiles (Q90, Q95).  
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ble 2 Contribution of circumstances (MLD) at different biomarker quantiles and 
Shapley decomposition. 
Waist to height ratio Q25 Q50 Q75 Q90 Q95 
MLD index 0.0040*** 0.0025*** 0.0014*** 0.0011*** 0.0008*** 
% contribution to IOp  
Age 68.89% 61.81% 52.93% 36.32% 34.00% 
Gender 12.73% 7.75% 1.27% 0.55% 1.99% 
Childhood language 0.40% 0.44% 0.35% 0.28% 0.27% 
Parental occupation 5.64% 9.37% 12.77% 15.71% 15.41% 
Parental education 5.29% 6.90% 7.69% 8.69% 8.90% 
Individual's Education 7.07% 13.69% 24.98% 38.35% 39.31% 
Systolic blood pressure Q25 Q50 Q75 Q90 Q95 
MLD index 0.0020*** 0.0022*** 0.0020*** 0.0020*** 0.0020*** 
% contribution to IOp  
Age 41.87% 57.46% 73.00% 77.04% 77.38% 
Gender 45.11% 29.58% 9.42% 3.12% 0.65% 
Childhood language 4.19% 2.11% 1.66% 1.11% 0.80% 
Parental occupation 2.79% 3.45% 5.49% 7.79% 7.32% 
Parental education 1.74% 2.60% 3.17% 3.32% 2.79% 
Individual's Education 4.29% 4.80% 7.25% 7.64% 11.11% 
Cholesterol ratio Q25 Q50 Q75 Q90 Q95 
MLD index 0.0039*** 0.0075*** 0.0090*** 0.0101*** 0.0076*** 
% contribution to IOp  
Age 34.28% 31.99% 29.98% 22.16% 25.27% 
Gender 55.15% 59.30% 63.68% 70.73% 64.48% 
Childhood language 0.03% 0.09% 0.12% 0.16% 0.01% 
Parental occupation 3.71% 3.67% 2.30% 1.92% 4.01% 
Parental education 3.38% 1.88% 0.84% 0.43% 0.89% 
Individual's Education 3.43% 3.07% 3.05% 4.61% 5.34% 
HbA1c Q25 Q50 Q75 Q90 Q95 
MLD index 0.0015*** 0.0022*** 0.0029*** 0.0064*** 0.0177*** 
% contribution to IOp  
Age 81.01% 78.23% 71.19% 64.85% 55.94% 
Gender 0.65% 0.68% 1.48% 3.88% 12.64% 
Childhood language 1.04% 0.59% 1.14% 2.00% 3.43% 
Parental occupation 6.63% 6.80% 7.07% 8.09% 7.63% 
Parental education 5.20% 4.15% 4.28% 4.43% 3.14% 
Individual's Education 5.40% 9.55% 14.91% 16.74% 17.21% 
 Q25 Q50 Q75 Q90 Q95 
MLD index 0.0356*** 0.0313*** 0.0239*** 0.0138*** 0.0073*** 
% contribution to IOP  
Age 46.10% 33.57% 20.79% 19.11% 14.43% 
Gender 1.00% 7.70% 15.25% 12.72% 4.49% 
Childhood language 0.27% 0.23% 0.72% 0.71% 0.70% 
Parental occupation 13.11% 13.60% 23.99% 21.77% 34.50% 
Parental education 14.43% 14.33% 11.65% 11.59% 15.21% 
Individual's Education 25.09% 30.57% 27.59% 34.09% 30.67% 
Fibrinogen  Q25 Q50 Q75 Q90 Q95 
MLD index 0.0041*** 0.0026*** 0.0026*** 0.0021*** 0.0017*** 
% contribution to IOp 
Age 66.80% 57.36% 52.76% 46.08% 42.19% 
Gender 8.27% 6.73% 6.90% 7.65% 4.66% 
Childhood language 0.63% 0.36% 0.94% 0.51% 0.23% 
Parental occupation 8.23% 10.47% 10.20% 10.61% 12.01% 
Parental education 4.49% 7.00% 5.55% 6.88% 9.41% 
Individual's Education 11.60% 18.09% 23.65% 28.27% 31.50% 
Allostatic load Q25 Q50 Q75 Q90 Q95 
MLD index 0.0028*** 0.0019*** 0.0011*** 0.0010*** 0.0009*** 
% contribution to IOP 
Age 66.00% 58.76% 53.08% 47.61% 41.44% 
Gender 12.50% 11.15% 7.84% 3.03% 5.53% 
Childhood language 0.27% 0.24% 0.38% 0.28% 1.11% 
Parental occupation 7.25% 6.97% 10.02% 15.85% 17.39% 
Parental education 5.18% 6.12% 5.49% 8.24% 7.52% 
Individual's Education 8.79% 16.77% 23.19% 25.00% 27.02% 
Bootstrapped standard errors in parenthesis. 
***P<0.01 
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These results highlight that the pronounced role of socioeconomic circumstances (parental 
occupation, parental education and own education) in shaping IOp at higher quantiles of 
the allostatic load distribution, would have been masked if the focus was solely on analysis 
at the mean (see subsection 4.1). Our “beyond the mean” analysis indicates that ill health 
is not simply a matter of gender and age inequalities, with our set of socioeconomic 
circumstances become much more relevant towards the right tails of biomarkers 
distribution, where clinical concerns are focused. These results are broadly consistent 
with previous “beyond the mean” studies that mainly focus on the role particular socio-
economic factors, extending the existing research to the IOp concept, where inequalities 
in health are based on a broader set of circumstance.  In their analyses, Carrieri and Jones 
(2017) and Costa-Font et al. (2009) found that the observed educational gradients become 
steeper towards the right tails of a selected set of blood-based biomarkers and the body 
mass index, respectively.  
 
Decomposition by gender and age 
Figure 5 presents gender differentials in the contribution of circumstances for allostatic 
load, based on our split sample analysis by gender implemented at various quantiles using 
the RIF method. The observed gender differentials at the lower quantiles of the 
distribution favour men; this echoes the analysis that uses estimates at the mean (Figure 
4). However, we find that these gender differentials decrease in magnitude towards the 
higher quantiles of the distribution of allostatic load, along with the absolute magnitude 
of the variation in outcomes across circumstances. These results indicate that moving to 
higher quantiles of the allostatic load distribution, gender differences in the role of 
circumstances on shaping health are less pronounced.   
 
Figure 6 presents the MLD indexes estimated separately for each age group using the 
fitted RIF values for each quantile (equation 7). We find that moving to the right tails of 
the allostatic load distribution, the inverted U-shaped pattern of IOp by age (observed for 
our “mean-based” IOp analysis; Figure 4) becomes less evident, with IOp gradually 
increasing with age. The cumulative advantage hypothesis (e.g., Kim and Durden, 2007), 
rather than the age-as-leveller, seems to exert the dominant role when the focus is on the 
right tail of the distribution, suggesting that adverse circumstances and health 
disadvantages accumulate as individuals age, suggesting a more pronounced role of 
circumstances in health as people age. The later  results further highlight that our set of 
circumstances other than age play a greater role in shaping inequalities where elevated 
health risks are prominent; this result would be masked if the focus was solely on IOp 
analysis at the mean (Figure 4) 
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Figure 5. Gender differentials in IOp across the distribution of allostatic load. 
 
 
 
Figure 6. IOp by age groups at different quantiles  
of allostatic load. 
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4.3. Sensitivity analysis: the role of mortality 
 
Mortality is obviously related to health and our analysis so far ignores the potential role 
of mortality bias by focusing on individuals who survived to UKHLS Wave 2. One may 
implicitly assume that the deceased would have achieved the average level of health 
associated with their circumstances and, thus, mortality bias may be disregarded in the 
ex-ante analysis of IOp in health. Specifically, in our analysis of IOp, we have adopted the 
ex ante approach - in the sense of comparing opportunity sets before effort has been 
exerted and the outcomes are realised. With the mean-based IOp all individuals are 
allocated the mean outcome given their circumstances (i.e. E(y|C)). This would also be 
true of any individuals who are missing due to death - as we are implicitly assigning them 
the mean outcome, consistent with the ex ante perspective. This makes the case that 
treating deaths as ignorable may be compatible with the ex ante mean-based IOp 
approach.  
 
However, by focusing on individuals who are survivors at Wave 2, we may under-
represent those individuals with lower socio-economic status, given that these people are 
more likely to die younger. This may or may not be a problem, depending on the scope of 
the analysis. If the focus of our paper is a description of the gradients in biomarkers across 
circumstances for the surviving population, there is no problem of survival bias and no 
additional analysis need to be taken. However, this is not the case if we are interested in 
accounting for the role of mortality in our ex ante IOp analysis.  
 
As one way to indicate the likely size and nature of mortality bias in our analysis, we 
extend the analysis by including those individuals who were alive at Wave 1 and are 
deceased at Wave 2, expanding our analysis sample for allostatic load by 179 individuals. 
UKHLS is representative of the UK population at Wave 1 and we can identify those 
individuals who are deceased at Wave 2. For those individuals deceased at UKHLS Wave 
2, all circumstance variables, except the childhood language variable, are collected at 
Wave 1; the fact that our set of circumstances are time invariant (date of birth has been 
used to calculate what the deceased’s age would have been at Wave 2), this allows us to 
pool the deceased sample with our main analysis sample and conduct sensitivity analysis 
with respect to mortality bias. We use three alternative imputation methods to generate 
an imputed observation for the deceased individuals’ allostatic load indicator: 
 
a) Random imputation (drawn from all non-deceased): hot-deck imputation from the 
gender and age-specific sample of non-deceased individuals with valid allostatic 
load measures at UKHLS wave 2;  
b) Random imputation (drawn from those deceased at subsequent waves): hot-deck 
imputation from the gender and age-specific sample of individuals who are alive 
at wave 2, but are deceased at subsequent UKHLS waves17; 
                                                             
17 Drawing from the sample of individuals who are deceased at subsequent waves allows us to 
impute allostatic load for the deceased based on a pool of valid allostatic load values of individuals 
who have excess risk of fragile health. The allostatic load distribution of those deceased at 
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c) Imputation of allostatic load values for the deceased individuals using a constant 
high allostatic load value (i.e., three s.d. above the mean). 
 
Table 3 presents inequality results for allostatic load and the Shapley decomposition of 
circumstances to IOp when accounting for mortality using the three alternative 
imputation methods. To recap here our sensitivity analysis, as opposed to the base case 
results, does not account for foreign language as a circumstance; however, this should not 
prevent us from making meaningful comparisons regarding the robustness of the base 
case results given the negligible contribution of the foreign language variable. We find 
virtually no differences (in terms of the total inequality, absolute and relative IOp) 
between the results based on the two random imputation procedures (Table 3) and our 
base case results for allostatic load (Table 1). Imputation using a constant high allostatic 
load value results into slightly higher total inequalities and IOp compared to our base 
case results, reflecting the fact that adding a constant high allostatic load to the deceased 
individuals increases the dispersion of the allostatic load distribution18. However, in any 
case, the Shapley decomposition on the percentage contribution of circumstance variables 
to IOp are similar between all imputation methods (Table 3) and our base case results 
(Figure 3).    
 
Table 3. IOp and Shapley decomposition accounting for mortality: Allostatic load 
Inequality index 
Random imputation 
(all non-deceased at wave 2) 
Random imputation 
(deceased at subsequent waves) 
Imputation: 3 s.d. above mean 
Total 
inequality 
Absolute 
IOp 
% of total 
inequality† 
Total 
inequality 
Absolute 
IOp 
% of total 
inequality† 
Total 
inequality 
Absolute 
IOp 
% of total 
inequality† 
MLD index 0.0073*** 0.0016*** 21.70 0.0075*** 0.0017*** 22.40 0.0087*** 0.0023*** 26.10 
Circumstances  % contribution of circumstances % contribution of circumstances % contribution of circumstances 
Age  60.15%   59.41%   55.03%  
Gender  10.40%   10.61%   8.45%  
Parental occupation  8.31%   8.25%   7.47%  
Parental education  6.16%   6.46%   12.75%  
Individual's Education  15.00%   15.18%   16.30%  
Total  100%   100%   100%  
Sample size 6,345 
Notes: Unlike the corresponding base case results (Table 1 and Figure 3), English language at home during childhood is missing in our set of 
circumstance variables here because of data availability for the deceased individuals at UKHLS Wave 2.  
†Relative IOp (column 3) stands for the (%) share of absolute IOp (column 2) to the total inequality (column 1) and reflect the contribution of observed 
circumstances to the total inequality in allostatic load.  
***P<0.01 
 
Table 4 presents the contribution of circumstances at different quantiles of the allostatic 
load distribution after accounting for mortality (using the alternative imputation 
procedures). Overall, Table 4 shows that the contribution of circumstances is similar to 
our base case results across the allostatic load quantiles (Table 2), with the role of socio-
                                                             
subsequent waves is less peaked and is skewed to the right compared to the corresponding 
allostatic load distribution for all individuals observed at Wave 2.   
18 One may argue that there is no practical or theoretical limitation for using a higher allostatic 
load values to impute the deceased’s missing allostatic load. Our evidence show that this will result 
in even higher inequalities, suggesting our current sensitivity analysis results as potential low 
bounds, which does not alter qualitatively the conclusions of our paper. 
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economic circumstances, as opposed to age and gender, increasing in magnitude as 
moving towards the higher quantiles of the allostatic load distribution.19 
 
 
 
Table 4. Contribution of circumstances at different allostatic quantiles and Shapley 
decomposition accounting for mortality bias. 
Panel A. Random imputation (all non-missing at wave 2) 
Allostatic load Q25 Q50 Q75 Q90 Q95 
MLD index 0.0029*** 0.0020*** 0.0011*** 0.0008*** 0.0007*** 
% contribution to IOP 
Age 66.67% 58.37% 54.03% 47.87% 42.55% 
Gender 11.89% 10.84% 8.27% 3.07% 5.58% 
Parental occupation 7.49% 7.03% 9.21% 16.18% 17.54% 
Parental education 5.27% 6.64% 6.01% 8.47% 7.53% 
Individual's Education 8.68% 17.12% 22.48% 24.41% 26.80% 
Panel B. Random imputation (deceased at subsequent waves) 
Allostatic load Q25 Q50 Q75 Q90 Q95 
MLD index 0.0029*** 0.0020*** 0.0012*** 0.0010*** 0.0009*** 
% contribution to IOP 
Age 66.49% 57.39% 53.40% 47.21% 39.46% 
Gender 11.97% 11.30% 8.41% 3.25% 5.59% 
Parental occupation 7.60% 7.18% 9.31% 14.29% 14.69% 
Parental education 5.32% 6.86% 6.81% 10.49% 13.50% 
Individual's Education 8.63% 17.27% 22.08% 24.75% 26.76% 
Panel C. Imputation: 3 s.d. above mean 
Allostatic load Q25 Q50 Q75 Q90 Q95 
MLD index 0.0030*** 0.0023*** 0.0019*** 0.0038*** 0.0053*** 
% contribution to IOP 
Age 66.15% 56.93% 51.98% 45.18% 44.50% 
Gender 11.61% 10.85% 5.32% 3.40% 3.04% 
Parental occupation 7.70% 6.90% 7.98% 9.45% 11.79% 
Parental education 5.52% 8.01% 13.06% 12.97% 13.13% 
Individual's Education 9.01% 17.30% 21.65% 29.00% 27.55% 
Notes: Unlike the corresponding base case results (Table 2), English language at home during childhood is 
missing in our set of circumstance variables here because of data availability for the deceased individuals at 
UKHLS Wave 2. 
***P<0.01 
 
 
Finally, to explore the robustness of our split sample IOp analysis by age across quantiles 
of the allostatic load distribution (Figure 6), we repeated our analysis using the three 
different imputation methods to account for the potential role of mortality (Figure A1, 
appendix). Overall, we find similar IOp patterns to the base case results, with IOp 
increasing with age as moving to higher quantiles of the allostatic load distribution (q90 
and q95). It should be noted that imputation using a high fixed value results in a much 
steeper increase in IOp by age when focusing at the higher quantiles of the allostatic load 
distribution (Panel C, Figure A1, Appendix); this echoes the higher IOp that we observe 
in the case of imputation based on a high constant value, further reinforcing our results 
with IOp being even higher at older ages when mortality bias is accounted for. 
                                                             
19 An exception here is the higher MLD index for the 90th and 95th allostatic load quantiles in the 
case of the imputation using a constant value (Table 4; Panel C) as opposed to the corresponding 
base case results (Table 2; allostatic load panel); this reflects the increased dispersion at the far 
right tails of the allostatic load distribution due to the use of a constant value to impute allostatic 
load values for the deceased. However, the corresponding results on the percentage contribution of 
circumstances (Shapley decomposition results for the 90th, 95th quantiles, Table 4, Panel C) reveal 
limited differences to our base case results. 
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5 Conclusions  
 
Using UK nationally representative data we explore ex ante IOp in health and its 
underlying sources using objective nurse-collected and blood-based biomarkers that are 
intended to reflect the risk of preventable chronic conditions, such as obesity, diabetes 
and cardiovascular health. We find that IOp accounts for a non-trivial part of the total 
variation in our health measures. For example, in the case of allostatic load, our composite 
health indicator regarded as a measure of cumulative wear and tear in a number of 
physiological systems, we find that about 20% of the total inequality is attributed to the 
role of circumstances (IOp). Shapley-decomposition techniques show that apart from age 
and gender, parental education, parental occupational status and own educational 
attainment are important sources of IOp.  
 
We propose an extension to the decomposition of ex ante IOp using the RIF method. This 
analysis allows us to decompose IOp and its sources across quantiles of the biomarker 
distribution. We find the presence of systematic contributions of circumstances for all 
biomarkers considered in our analysis across the whole distribution. In most cases, the 
contribution of age and sex declines relative to socioeconomic circumstances in the right 
tails, the part of the distribution where health risks are more pronounced. Focusing on 
allostatic load, the contribution of all socioeconomic circumstances increases from 21% at 
the lowest quantiles to more than 50% at the higher quantiles of the allostatic load 
distribution. Analysis focusing solely “at the mean” masks the important role of our set of 
socioeconomic circumstances (i.e., parental occupation, parental education and own 
education) on shaping health inequalities towards the right tails of biomarkers 
distribution, where clinical concerns are focused. Our “beyond the mean” analysis indicate 
that ill health is not simply a matter of gender and age inequalities, with our results 
confirming and extending existing research on the long-lasting role of childhood 
socioeconomic status (e.g., Case et al., 2005; Cohen et al., 2010) in the context of the IOp 
in health.  
 
We also estimated IOp in our composite biomarker measure (allostatic load) by gender 
and across age groups. Splitting our sample by gender we find pronounced IOp in 
allostatic load (attributed to all measured circumstances apart from gender), with the 
gender differences in IOp in allostatic load being less relevant at the right tails of the 
allostatic load distribution. Our split sample analysis by age reinforces our finding that 
socio-economic circumstances play a greater role on shaping inequalities as people age 
towards the tails of the distribution where the health risks are much more prominent.  
 
Given that IOp has been of interest to the health policy agenda (e.g., NHS England, 2017, 
NHS, 2019) and it has been placed at the top of the ‘inequality of what’ debate by relevant 
institutions (e.g. World Bank, 2005), more insight on the measurement of IOp is of 
particular importance. Our proposed methodology, over and above the specific application 
to health, may contribute and motivate “beyond the mean” analysis in the context of 
measuring and analysing IOp in several other dimensions of individuals’ well-being, 
where focusing on the tails of the distribution is of particular importance.    
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Appendix 
Table A1. Circumstance variables  
used in the analysis. 
 Mean 
Age groups  
16-25 0.075 
26-35 0.126 
36-45 0.183 
46-55 0.188 
56-65 0.190 
66-75 0.147 
76+ 0.091 
Gender  
Male  0.432 
Female  0.568 
Language at home during childhood  
English at childhood 0.930 
Other language at childhood  0.070 
Mother occupation  
1(low-skilled) 0.144 
2 0.258 
3 0.084 
4(high-skilled)  0.084 
Missing 0.030 
Not working (reference) 0.400 
Father occupation  
1(low-skilled) 0.087 
2 0.238 
3 0.386 
4(high-skilled)  0.146 
Missing 0.089 
Not working (reference) 0.054 
Highest parental education  
No/some qualification (reference) 0.501 
Post-school qualification/certificate 0.247 
Degree 0.100 
Missing 0.151 
Educational attainment  
No/basic qualification (reference) 0.150 
O-level 0.315 
A-level/post-secondary  0.310 
Degree 0.224 
 
 
 
Table A2. Descriptive statistics for biomarkers 
for the full and restricted samples. 
 Full sample Excluding missing parental data 
 Mean Std. err. Sample size Mean Std. err. Sample size 
Waist-to-height ratio 0.561 0.001 14,068 0.560 0.001 11,119 
Systolic blood pressure 
(mmhg) 
126.17 0.155 11,865 126.00 0.161 9,450 
Cholesterol ratio 3.741 0.014 9,005 3.732 0.016 7,228 
HbA1c (mmol/mol) 37.240 0.082 8,468 37.111 0.090 6,803 
CRP (mg/L) 2.092 0.022 8,311 2.044 0.024 6,672 
Fibrinogen (g/L)  2.789 0.006 8,964 2.782 0.007 7,199 
Allostatic load 27.475 0.043 6,166 27.380 0.047 4,976 
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Table  IOp measures and Shapley decomposition using different inequality measures.  
 
Measures of IOp 
Shapley decomposition: 
% contribution of circumstances to IOp 
 Absolute 
IOp 
Relative 
IOp 
Age Gender 
Childhood 
language 
Parental 
occupation 
Parental 
education 
Individual’s 
education 
Total 
contribution 
MLD index‡          
Waist to height ratio 0.0020*** 0.169*** 64.68% 5.48% 0.36% 8.01% 6.83% 14.63% 100% 
Systolic blood pressure 0.0017*** 0.198*** 61.96% 21.94% 2.56% 4.34% 2.82% 6.38% 100% 
Cholesterol ratio 0.0064*** 0.110*** 29.46% 63.40% 0.03% 2.27% 1.20% 3.64% 100% 
HbA1c 0.0030*** 0.195*** 70.73% 2.95% 1.84% 7.09% 4.54% 12.85% 100% 
C-reactive protein 0.0161*** 0.039*** 23.41% 10.15% 0.42% 20.24% 13.26% 32.52% 100% 
Fibrinogen 0.0023*** 0.107*** 58.61% 8.18% 0.48% 9.50% 4.98% 18.26% 100% 
Allostatic load  0.0016*** 0.218*** 59.68% 10.57% 0.24% 8.34% 5.90% 15.28% 100% 
          
Variance share†          
Waist to height ratio - 0.161*** 63.80% 5.60% 0.40% 8.10% 6.80% 15.40% 100% 
Systolic blood pressure - 0.191*** 61.90% 22.00% 2.50% 4.30% 2.80% 6.50% 100% 
Cholesterol ratio - 0.095*** 28.51% 64.44% 0.03% 2.23% 1.18% 3.61% 100% 
HbA1c - 0.146*** 70.20% 3.00% 1.80% 7.00% 4.40% 13.60% 100% 
C-reactive protein - 0.033*** 24.10% 10.00% 0.40% 19.10% 11.0% 35.40% 100% 
Fibrinogen - 0.105*** 58.30% 8.20% 0.50% 9.30% 4.80% 18.90% 100% 
Allostatic load  - 0.210*** 59.12% 10.70% 0.24% 8.28% 5.83% 15.83% 100% 
Notes: 
‡The results using the MLD index are the same to those presented in Table 1 and Figure 3 (main text). As in Table 1, relative IOp stands 
for the proportion of the total inequality in biomarkers that is attributed to IOp but, unlike Table 1, here is not expressed in percentage 
terms.  
†The variance share is by definition a relative measure of IOp, capturing the share of the total variation in each biomarker that is attributed 
to the observed circumstances.  
***P<0.01 
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Figure A1. IOp by age groups at different quantiles of allostatic load distribution accounting for mortality bias 
Panel A: Random imputation (all non-missing at wave 2) Panel B: Random imputation (deceased at subsequent waves) 
Panel C: Imputation: 3 s.d. above mean  
 
 
Notes; Red line indicates a scale break (y axis) for the case of the last graph above.  
 
 
 
